SCHEMBL3576407

SCHEMBL3576407

CCn1c(C)cn(CC(=O)O)c1=O

nearest known ligand 0.46

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
POLB P06746 2/20 0.46
MAPT P10636 2/20 0.46
KDM4E B2RXH2 2/20 0.46
ALDH1A1 P00352 2/20 0.46
LMNA P02545 3/20 0.40
APEX1 P27695 1/20 0.38
KMT2A Q03164 4/20 0.36
MEN1 O00255 2/20 0.36
PKM P14618 2/20 0.36
PSMD14 O00487 1/20 0.36
GFER P55789 1/20 0.36
ADORA2B P29275 1/20 0.36
ABCC4 O15439 1/20 0.33
PTGS1 P23219 1/20 0.33
GRIN2D O15399 1/20 0.33
GRIN3B O60391 1/20 0.33
GRIA1 P42261 1/20 0.33
GRIA2 P42262 1/20 0.33
GRIA3 P42263 1/20 0.33
GRIA4 P48058 1/20 0.33

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL3591763 0.86 KDM4E (0.42) POLBMAPTKDM4EALDH1A1LMNA
SCHEMBL24666582 0.83 KDM4E (0.44) POLBMAPTKDM4EALDH1A1LMNA
SCHEMBL27506471 0.81 POLB (0.39) POLBMAPTKDM4EALDH1A1LMNA
SCHEMBL21900263 0.78 CDK9 (0.44) POLBMAPTKDM4EALDH1A1LMNA
SCHEMBL3582007 0.78 ALDH1A1 (0.39) POLBKDM4EALDH1A1KMT2A
SCHEMBL3987251 0.72 POLB (0.46) POLBMAPTKDM4EALDH1A1APEX1
SCHEMBL30178378 0.72 MAPT (0.38) POLBMAPTKDM4EALDH1A1APEX1
SCHEMBL19873934 0.72 MAPT (0.38) POLBMAPTKDM4EALDH1A1APEX1
SCHEMBL3591122 0.70 APEX1 (0.44) POLBMAPTKDM4EALDH1A1LMNA
SCHEMBL30004036 0.70 APEX1 (0.52) KDM4EALDH1A1LMNAAPEX1KMT2A

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 3 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-20100286191-A1 2-Arylthiazole Derivatives as CXCR3 Receptor Modulators MERCK SHARP & DOHME CORP. 2010-11-11 US disclosed
US-20100286191-A1 2-Arylthiazole Derivatives as CXCR3 Receptor Modulators MERCK SHARP & DOHME CORP. 2010-11-11 US disclosed
US-20100286191-A1 2-Arylthiazole Derivatives as CXCR3 Receptor Modulators MERCK SHARP & DOHME CORP. 2010-11-11 US disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20100286191-A1 2-Arylthiazole Derivatives as CXCR3 Receptor Modulators CXCR3, CXCR1, CXCR2 POLB 4548/4885MAPT 4292/4885KDM4E 3447/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.